Evonik stock gains as stronger Q3 lifts full-year outlook

Evonik reported a stronger third quarter on Tuesday, November 3, as adjusted EBITDA rose 40 percent year on year to 629 million euros. The specialty chemicals group said the result supports a more optimistic view of its full-year performance, while Reuters reported that the quarterly figure came in slightly below the 633.2 million euro analyst consensus compiled by Vara Research.

The company kept its 2026 adjusted EBITDA range at 2.0 billion to 2.2 billion euros but now expects to land in the upper half. It also expects fourth-quarter earnings to exceed the prior-year level. Interim Chief Executive Claus Rettig said the outlook had become more encouraging despite weak economic growth and geopolitical tensions, according to Reuters.

Higher Profitability Meets Cautious Demand

The third-quarter improvement gives Evonik more room to absorb a difficult industrial backdrop. The earnings recovery is particularly relevant because the group is still operating in markets where demand remains uneven and external shocks can affect volumes, prices and supply chains. Management's guidance points to continued operational progress rather than a broad-based demand recovery.

Evonik's investor-relations page said the company published its third-quarter report on November 3 and linked the stronger operating performance to an expected result in the upper half of its guidance range. The company has not replaced the existing full-year range, so the change is an outlook refinement rather than a new numerical target.

Capacity Expansion Adds Strategic Support

Evonik also completed a 52 million euro expansion of its silicone platform in Essen, according to the company's investor-relations materials. The project includes a new production plant and tank farm for organomodified silicones used in insulation materials, automotive seating, adhesives, coatings and personal-care applications.

The Essen investment is intended to strengthen supply security and reduce the need to transport intermediates and finished products between sites. For investors, the project adds longer-term capacity and network resilience, while the quarterly report remains the more immediate driver of the earnings outlook.

Evonik stock traded at 21.56 euros on Lang & Schwarz at 12:21 CET on Thursday, November 5, 2026, 0.94 percent above the Xetra close of Wednesday, November 4. The real-time quote of Evonik stock provides the latest market view.

The main risk for the outlook is that weak economic growth and geopolitical tensions continue to restrain industrial demand. The next scheduled quarterly report is the Q4 2026 publication on March 4, 2027, according to Evonik's investor-relations calendar.

The broader DAX market environment remains relevant for the valuation of German cyclical shares.

For additional company-specific coverage, see More news and analyses on Evonik stock.

Reuters reported the quarterly earnings comparison and management outlook. Evonik's investor-relations page provides the company's reporting calendar and Q3 release information.